Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 10, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001000275-23-000036.pdf
Aug 09, 2023	SC TO-C	Written public communication relating to an issuer or third party tender offer	View HTML 0001104659-23-089313.pdf 0001104659-23-089313.xls
Aug 03, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-23-000021.pdf 0001804220-23-000021.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 03, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-23-000023v2.pdf 1.2 MB 0001804220-23-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000019.pdf 0001968202-23-000019.xls
Aug 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000075.pdf 0001883850-23-000075.xls
Aug 01, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-002671.pdf 0001950047-23-002671.xls
Jul 06, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000016.pdf 0001968202-23-000016.xls
Jul 06, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000017.pdf 0001968202-23-000017.xls
Jul 03, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001968582-23-000294.pdf 0001968582-23-000294.xls

Data provided by Kaleidoscope.

Investors & Media